N
FMTX

Nuveen’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Nuveen’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200,901
Closed -$4.01M – 3313
2022
Q3 		$4.01M Sell
200,901
-13,458
-6% -$177K ﹤0.01% 2026
2022
Q2 		$1.48M Buy
214,359
+91,615
+75% +$643K ﹤0.01% 2603
2022
Q1 		$1.15M Buy
122,744
+1,291
+1% +$13.7K ﹤0.01% 2767
2021
Q4 		$1.59M Sell
121,453
-7,587
-6% -$131K ﹤0.01% 2683
2021
Q3 		$3.06M Sell
129,040
-11,789
-8% -$279K ﹤0.01% 2472
2021
Q2 		$3.5M Buy
140,829
+8,025
+6% +$216K ﹤0.01% 2427
2021
Q1 		$3.72M Buy
132,804
+68,232
+106% +$2.46M ﹤0.01% 2317
2020
Q4 		$2.25M Buy
64,572
+2,149
+3% +$93.6K ﹤0.01% 2447
2020
Q3 		$3.11M Buy
+62,423
New +$2.52M ﹤0.01% 2157

Nuveen's FMTX Position: Q4 2022 in Review

Nuveen sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 200,901 shares — an estimated $4.01M sold.

Nuveen first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $4.01M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Nuveen reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 200,901 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $4.01M.
  • Nuveen first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Nuveen's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.01M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.